New Sensor Chip Shows Promise for Rapid, Low-Cost POC Disease Diagnostics
|
By LabMedica International staff writers Posted on 27 Jun 2023 |

The Loop-Mediated Isothermal Amplification (LAMP) technique is a popular method for identifying pathogens by amplifying their DNA. The detection of LAMP-amplified products, such as the DNA of pathogens, typically requires the use of fluorescent dyes to "label" these products, which can be expensive and have low sensitivity. Now, researchers have designed a new sensor capable of diagnosing pathogens without the need for these reagents and with a high degree of sensitivity. This new development also eliminates the time-consuming process of DNA purification, which often poses challenges for point-of-care applications.
Scientists at Texas A&M AgriLife Research (College Station, TX, USA) in collaboration with Iowa State University (Ames, IA, USA) have developed a sensor chip capable of identifying numerous disease-causing pathogens with ten times the sensitivity of existing techniques. The sensor chip eliminates the need for chemical dye reagents typically employed in diagnostics. The innovative chip consists of a nanopore thin-film sensor housed within a unique reaction chamber. Uniquely designed primers are immobilized on the nanofilm, causing the amplified LAMP products to bind to the sensor. The resulting signals can then be directly and easily measured using a portable spectrometer. The sensor delivers results within approximately 30 minutes. This new technology holds the promise of rapid, inexpensive point-of-care diagnostics in various sectors, including plants, food, animals, and human health, including the detection of foodborne pathogens, bird flu, and COVID-19.
In their study, the researchers used the innovative sensor to identify Phytophthora infestans, a pathogen that causes the highly destructive late blight disease, posing a significant threat to potato and tomato crops worldwide. The LAMP chip offers a new portable platform for pathogen detection, employing label-free sensors with exceptional sensitivity. The research team will now focus on increasing its sensitivity to the subattomolar levels or even lower. They aim to overcome the existing challenges in identifying and differentiating pathogen species and strains that share high sequence similarities. The team also plans to improve detection specificity and implement quantitative detection by integrating artificial intelligence and CRISPR gene-editing technologies. Their goal is to develop a feasible product for wide-ranging use in plant, animal, and human health point-of-care applications.
“This research advances technologies that have emerged as some of our greatest opportunities for improving agriculture, food safety and human health,” said Junqi Song, Ph.D., associate professor and plant immunity research lead with AgriLife Research. “Our publication represents a step toward realizing these powerful tools against diseases.”
Related Links:
Texas A&M AgriLife Research
Iowa State University
Latest Technology News
- Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
- New Electronic Pipette Enhances Workflows with Touchscreen Control
- AI Model Outperforms Clinicians in Rare Disease Detection
- AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
- Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms
- AI-Powered Biomarker Predicts Liver Cancer Risk
- Robotic Technology Unveiled for Automated Diagnostic Blood Draws
- ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Channels
Clinical Chemistry
view channel
Simple Urine Home Test Kit Could Detect Early-Stage Breast Cancer
Breast cancer is the most commonly diagnosed cancer among women globally and remains a leading cause of cancer-related deaths in more than 100 countries. Current diagnostic pathways rely on mammography,... Read more
New Tool Tracks Biomarker Changes to Predict Myeloma Progression
Smoldering multiple myeloma (SMM) precedes multiple myeloma and poses a monitoring challenge because progression risk varies widely among patients. Static, one-time laboratory assessments can miss clinically... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
Early identification of treatment response and relapse remains a major challenge in solid tumors, where minimal residual disease is difficult to detect with routine imaging and blood tests.... Read more
Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response
Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read moreMicrobiology
view channel
Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
Accurate and rapid identification of bacterial infections remains challenging in acute care, where delays can hinder timely, targeted therapy. Infectious diseases are a major cause of mortality worldwide,... Read more
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read morePathology
view channel
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read more
New Chromogenic Culture Media Enable Rapid Detection of Candida Infections
Invasive Candida infections are challenging for healthcare systems, with some strains spreading rapidly in hospitals and showing resistance to multiple antifungal drugs. Candida auris is associated with... Read moreTechnology
view channel
Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
Pneumonia is commonly confirmed with chest X-rays or laboratory assays that can take hours, delaying clinical decisions in acute and outpatient settings. Breath-based diagnostics promise faster answers... Read more
New Electronic Pipette Enhances Workflows with Touchscreen Control
Manual pipetting remains a routine yet error-prone step that can affect reproducibility and throughput in clinical and research laboratories. Training demands and ergonomic strain also add variability... Read more
AI Model Outperforms Clinicians in Rare Disease Detection
Rare diseases affect an estimated 300 million people worldwide, yet diagnosis is often protracted and error-prone. Many conditions present with heterogeneous signs that overlap with common disorders, leading... Read more
AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
Periprosthetic joint infection (PJI) is a rare but serious complication affecting 1% to 2% of primary joint replacement surgeries. The condition occurs when bacteria or fungi infect tissues around an implanted... Read moreIndustry
view channel
Co-Diagnostics Agreement Expands Commercial and Distribution Reach in South Asia
Co-Diagnostics (Co-Dx; Salt Lake City, UT, USA) has signed an agreement for CoSara Diagnostics Pvt. Ltd., its Indian joint venture with Ambalal Sarabhai Enterprises Limited (Ahmedabad, India), to extend... Read more




.jpg)



